Meeting
2012 ASCO Annual Meeting
The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
Authors
MARK Krasnik
Rigshospitalet, Copenhagen, Denmark
MARK Krasnik , Margreet Lüchtenborg , Erik Jakobsen , Karen Linklater , Anders Mellemgaard , Henrik Møller
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 7026)
DOI
10.1200/jco.2012.30.15_suppl.7026
Abstract #
7026
Poster Bd #
18
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
The impact of HIV and CD4 count stratification on all cause mortality for adenocarcinoma and squamous cell lung cancers in the antiretroviral therapy era: Analysis of National Veterans Affairs and Kaiser Permanente Northern cohorts.
First Author: Elizabeth Y. Chiao
Poster
2023 ASCO Annual Meeting
Two-year lung cancer survival between 2000 to 2020: Results from 3 French nationwide cohorts.
First Author: Didier Debieuvre
Poster
2021 ASCO Annual Meeting
Association of low RKIP expression with poor prognosis in non-small cell lung cancer.
First Author: Lingbin Meng
Poster
2019 ASCO Annual Meeting
Comorbidity and racial differences in risk of mortality of men with breast cancer.
First Author: Carol Parise